抗血管内皮生长因子生物类药物用于老化眼睛
Ashish Sharma1, Jay U Sheth2, Baruch D Kuppermann3
1Lotus Eye Hospital and Institute, Coimbatore, Tamil Nadu, India. drashish79@hotmail.com.
Drugs & aging
|March 17, 2026
概括
抗血管内皮生长因子 (抗VEGF) 生物仿制药为像nAMD这样的视网膜疾病提供了具有成本效益的替代方案. 虽然显示出可比有效性,但采用和营销后监测方面的挑战仍然是关键考虑因素.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 神经血管与年龄相关的黄斑变性 (nAMD) 是导致视力丧失的主要原因.
- 抗血管内皮生长因子 (抗VEGF) 疗法是对nAMD和其他视网膜血管疾病的标准治疗方法.
- 抗VEGF生物制品的高成本需要替代治疗选择.
研究的目的:
- 审查当前针对视网膜疾病的抗VEGF生物类似药的情况.
- 评估这些生物类似药的临床疗效,安全性和经济影响.
- 解决眼科实践中生物类似整合的挑战和未来方向.
主要方法:
- 对正在开发和批准的抗VEGF生物类似药的文献审查.
- 对临床试验数据对疗效和安全性的分析.
- 检查监管,医生和患者接受因素.
主要成果:
- 一些抗VEGF生物仿制药 (例如,贝瓦齐祖马布,拉尼比祖马布,阿弗利伯塞普特) 正在开发/批准.
- 生物类似药在nAMD中显示了可比的视敏度改善和视网膜液减少.
- 挑战包括监管障碍,接受和需要营销后监督.
结论:
- 抗VEGF生物仿制药为管理nAMD和其他视网膜血管疾病提供了一个有希望的,具有成本效益的选择.
- 成功的整合需要解决监管,验收和安全监控方面的挑战.
- 预计持续的数据生成和批准将增加眼科中生物类似药的使用.
更多相关视频
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.7K
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.5K
相关概念视频
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
Ophthalmic Drug Delivery Systems
173
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
173
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
